क्यूआर कोड

Potentiating Antibody-Dependent Cellular Cytotoxicity in Triple-Negative Breast Cancer via the Humanized Anti-CD147 Antibody

Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with high metastatic potential, poor prognosis, and the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). The lack of these receptors limits the standard treatments, su...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Kanyarat Thongheang, Thanathat Pamonsupornwichit, Kanokporn Sornsuwan, On-anong Juntit, Tawan Chokepaichitkool, Weeraya Thongkum, Umpa Yasamut, Chatchai Tayapiwatana
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI AG 2025-04-01
श्रृंखला:Antibodies
विषय:
triple-negative breast cancer
CD147
antibody therapy
ADCC
humanized antibody
ऑनलाइन पहुंच:https://www.mdpi.com/2073-4468/14/2/36
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन